[1] GEORGE PM,BADIGER R,ALAZAWI W,et al.Mitchell,pharmacology and therapeutic potential of interferons[J].Pharmacol Ther,2012,135(1):44
[2] 王军志.生物技术药物研究开发和质量控制[M].第三版.北京:科学出版社,2018:467 WANG JZ.Research,Development and Quality Control of Biopharmaceuticals[M].3th ed.Beijing:Science Publishers,2018:467
[3] PLATANIAS LC.Interferons and their antitumor properties[J].Interferon Cytokine Res,2013,33(4):143
[4] LAROCQUE L,BLIU A,XU R,et al.Bioactivity determination of native and variant forms of therapeutic interferons[J].J Biomed Biotechnol,2011,2011:174615
[5] LI Y,RAO C,TAO L,et al.Improved detection of variants in recombinant human interferon alpha-2a products by reverse-phase high-performance liquid chromatography on a core-shell stationary phase[J].J Pharm Biomed Anal,2013,88C:123
[6] 李永红,韩春梅,裴德宁,等.2种重组人干扰素α-2b相关蛋白分析方法的应用比较[J].药物分析杂志,2014,34(7):1204 LI YH,HAN CM,PEI DN.et al.Comparison of two methods in analyzing recombinant human interferon α-2b related proteins[J].Chin J Pharm Anal,2014,34(7):1204
[7] JENKINS N,MURPHY L,TYTHER R.Post-translational modifications of recombinant proteins:significance for biopharmaceuticals[J].Mol Biotechnol,2008,39(2):113
[8] JENKINS N.Modifications of therapeutic proteins:challenges and prospects[J].Cytotechnology,2007,53(1-3):121
[9] SINGH SK.Impact of product-related factors on immunogenicity of biotherapeutics[J].J Pharm Sci,2011,100(2):354
[10] AHRER K,JUNGBAUER A.Chromatographic and electrophoretic characterization of protein variants[J].J Chromatogr B Analyt Technol Biomed Life Sci,2006,841(1-2):110
[11] BRACEWELL DG,SMALES CM.The challenges of product-and process-related impurities to an evolving biopharmaceutical industry[J].Bioanalysis,2013,5(2):123
[12] ALDINI G.Advanced analytical strategies for recombinant therapeutic proteins[J].Curr Pharm Biotechnol,2011,12(10):1507
[13] DUVAL E,BROLY H,GLEIXNER R.Quality attributes of recombinant therapeutic proteins:an assessment of impact on safety and efficacy as part of a quality by design development approach[J].Biotechnol Prog,2012,28(3):608
[14] EP.9.5[S].2016:2780
[15] MARK JK,DIONNE S,CYR TD,et al.Utility of standard pharmacopeial and nonpharmacopeial methods in distinguishing folded,unfolded,and process variant forms of interferon α-2[J].J Pharm Sci,2012,101(10):3672
[16] 中华人民共和国药典2015年版.三部[S]:2015:297 ChP 2015.Vol Ⅲ[S]:2015:297